• About USC/Norris
  • Mission and Vision
  • NCI Designation
  • Leadership
  • Organization Chart
  • Members
  • Programs & Focus Areas
  • Publications
  • History
• Patient Care
• Research
• Clinical Trials
• Faculty
• Education
• Future at USC/Norris
• Core Facilities
• Support USC/Norris

Genitourinary Cancers Program

The Genitourinary Cancers Program is a multidisciplinary program focused on the pathogenesis, diagnosis, prevention and treatment of genitourinary malignancies.

While this program has emphasized and will continue emphasize on bladder and prostate cancers (the most common genitourinary malignancies), the program is developing increasing emphasis in renal and testicular cancer, as well.

The program holds these scientific goals:

• Study the molecular genetic basis for genitourinary tumorigenesis.
• Examine molecular aspects of genitourinary cancer progression and translate discoveries into novel diagnostic and therapeutic strategies.
• Examine the epidemiology of genitourinary cancer to develop hypotheses regarding possible causation, molecular etiology and novel prevention strategies.
• Develop and test new surgical, chemotherapeutic, radiotherapeutic, biologic and combined modality approaches to the treatment of genitourinary cancer.

These goals are being addressed using our considerable strengths in epidemiology, basic research, translational research and clinical investigation.

Current research under the program includes a study of the key molecular and cellular determinants of bladder cancer causation and progression.

The program contains 26 members from eight departments.

Publications